Objective: To study the impact of the arcuate uterus on euploid blastocyst-stage embryo transfer outcomes after comprehensive chromosomal screening (CCS).
Design: Controlled retrospective trial.
Setting: Tertiary care assisted reproduction technology (ART) center.